In a groundbreaking development, researchers at the Indian Institute of Technology, Guwahati, have partnered with global leaders from Duke-NUS Medical School, National University of Singapore, and the University of Michigan to introduce a novel, multi-stage clinical trial method. This advancement aims to revolutionise personalised medical care by customising treatment regimens in real-time based on each patient’s individual responses.
ಡೆಂಗಿ ಜ್ವರದ ಲಕ್ಷಣಗಳನ್ನು ನಿರ್ಲಕ್ಷಿಸಬೇಡಿ. ಹತ್ತಿರದ ಸರ್ಕಾರಿ ಆಸ್ಪತ್ರೆಗೆ ಭೇಟಿ ನೀಡಿ ಉಚಿತ ಪರೀಕ್ಷೆ ಹಾಗೂ ಚಿಕಿತ್ಸೆ ಪಡೆಯಿರಿ.#Dengue #DenguePrevention
.
.@dineshgrao @Comm_dhfwka pic.twitter.com/82i3Kit5QC
ಡೆಂಗಿ ಜ್ವರದ ಲಕ್ಷಣಗಳನ್ನು ನಿರ್ಲಕ್ಷಿಸಬೇಡಿ. ಹತ್ತಿರದ ಸರ್ಕಾರಿ ಆಸ್ಪತ್ರೆಗೆ ಭೇಟಿ ನೀಡಿ ಉಚಿತ ಪರೀಕ್ಷೆ ಹಾಗೂ ಚಿಕಿತ್ಸೆ ಪಡೆಯಿರಿ.#Dengue #DenguePrevention
.
.@dineshgrao @Comm_dhfwka pic.twitter.com/82i3Kit5QC
IIT Guwahati’s Innovative Trial Method Paves Way for Personalised Healthcare
Date:
More like thisRelated
Karnataka’s Pre-Monsoon Showers Claim 71 Lives, Cause Widespread Damage
Bengaluru: The office of Karnataka Chief Minister Siddaramaiah announced...
Bengaluru Records One More COVID-19 Death, 58 New Cases Reported
Bengaluru: In a somber update, the state has recorded...
Karnataka and Tamil Nadu Information Commission Chiefs Explore Information Governance Synergies
Bengaluru: Tamil Nadu State Information Commissioner Shakeel Akhtar made...
Manivannan P. Assumes Role as BDA Commissioner
Manivannan succeeds N. Jayaram, who retired from the position of BDA Commissioner on Saturday, May 31. A officer from the 1998 batch, Manivannan brings a wealth of experience to this critical role in urban development.